Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × GastroEsophageal Cancer × Lapatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 30 Neoplasm Metastasis 6 Neoplasms 4 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Esophageal Neoplasms 2 Carcinoma, Squamous Cell 2 Breast Neoplasms, Male 2 Skin Neoplasms 1 Recurrence 1 Metastatic Breast Cancer With Intracranial Metastases 1 Melanoma 1 Inflammatory Breast Neoplasms 1 Her2 Positive Metastatic Breast Cancer 1 Head and Neck Neoplasms 1 HER2 Positive Esophagogastric Cancer 1 GastroEsophageal Cancer 1 Esophageal Squamous Cell Carcinoma 1 Diarrhea 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Ductal, Breast 1 Carcinoma 1 Breast Diseases 1 Brain Neoplasms 1 Advanced Solid Tumors 1

Interventions

Lapatinib 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01145404 2014-07-02

GastroLap

National Center for Tumor Diseases, Heidelberg

Phase 2 Terminated

Gastrointestinal

GastroEsophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡